BI
Beijing Immupeutics Medicine Technology at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Beijing Immupeutics Medicine Technology brings 2 presentations to SITC 2026 in Phoenix. Its program centres on making TCR-T cells directly inside the body with lipid nanoparticles that carry mRNA. Its targets include MAGE-A1 and the KRAS G12V mutation, with nanoparticles steered to T cells through CD8 or CD7.
| Organization | SITC 2026 Attendance |
|---|---|
BI Beijing Immupeutics Medicine Technology Beijing, China | |
Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12:30–1:30pm 6:40–8:10pm |
Instantly find 20 buyers from Beijing Immupeutics Medicine Technology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction